What amount sold does Holobiome, Inc. report in Form D filings?

The latest linked filings report $17.5M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Holobiome, Inc.'s most recent SEC filing?

Holobiome, Inc.'s most recent Form D filing was on 2026-07-22.

How many investors does Holobiome, Inc. have?

The most recent Form D filing lists 5 investor(s).

Holobiome, Inc.

CIK: 0001763027·Biotechnology·BOSTON, MA·Corporation

Reported Sold

$17,515,554

Total Filings

Identified Offerings

Last Filed

Jul 22, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 22, 2026Form D — New notice

Reported sold: $10,000,000 · Target: $10,000,000

Rule 506(b)·5 investors

Mar 20, 2024Form D — New notice

Reported sold: $6,590,554 · Target: $9,361,054

Rule 506(b)·19 investors

Feb 11, 2021Form D — New notice

Reported sold: $300,000 · Target: $2,000,000

Rule 506(b)·2 investors

Dec 28, 2018Form D — New notice

Reported sold: $625,000 · Target: $1,250,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 4 identified offerings

$17,515,554

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Michael Lafleur

Related Person

Appears on 2 filings

Kim Lewis

Related Person

Appears on 2 filings

Joan LaRovere

Related Person

Appears on 1 filing

Michael LaFleur

Related Person

Appears on 1 filing

Phil Strandwitz

Related Person

Appears on 1 filing

Iain Chessell

Related Person

Appears on 1 filing

Philip Strandwitz

Related Person

Appears on 1 filing

Philip Strandwitz

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 22, 2026	New	$10,000,000	$10,000,000	5
Mar 20, 2024	New	$9,361,054	$6,590,554	19
Feb 11, 2021	New	$2,000,000	$300,000	2
Dec 28, 2018	New	$1,250,000	$625,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Auron Therapeutics, Inc.

Biotechnology

Offering target: $12,000,000

Filed Aug 13, 2026